BI Asset Management Fondsmaeglerselskab A S Buys 79,742 Shares of DaVita Inc. (NYSE:DVA)

BI Asset Management Fondsmaeglerselskab A S raised its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 153.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 131,873 shares of the company's stock after buying an additional 79,742 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S owned 0.16% of DaVita worth $19,722,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of DVA. SBI Securities Co. Ltd. bought a new stake in shares of DaVita in the fourth quarter valued at about $41,000. Canada Post Corp Registered Pension Plan bought a new stake in shares of DaVita in the 4th quarter worth approximately $55,000. Venturi Wealth Management LLC grew its holdings in shares of DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after purchasing an additional 152 shares in the last quarter. Versant Capital Management Inc lifted its position in DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after purchasing an additional 169 shares during the period. Finally, Blue Trust Inc. increased its holdings in DaVita by 39.7% in the 4th quarter. Blue Trust Inc. now owns 461 shares of the company's stock valued at $76,000 after buying an additional 131 shares during the period. Institutional investors own 90.12% of the company's stock.

DaVita Trading Down 0.7 %

DVA traded down $0.97 during mid-day trading on Friday, reaching $138.59. The stock had a trading volume of 310,126 shares, compared to its average volume of 837,892. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita Inc. has a 52 week low of $130.96 and a 52 week high of $179.60. The stock has a market capitalization of $11.09 billion, a P/E ratio of 12.94, a P/E/G ratio of 1.07 and a beta of 1.04. The firm's fifty day simple moving average is $146.81 and its two-hundred day simple moving average is $155.40.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, equities analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have recently commented on DVA. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a report on Friday, February 21st. Cowen reissued a "hold" rating on shares of DaVita in a report on Tuesday, February 18th. StockNews.com upgraded DaVita from a "hold" rating to a "buy" rating in a research report on Thursday, April 10th. Finally, Barclays raised their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat, DaVita currently has a consensus rating of "Hold" and an average target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.